A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Clinical trial NCT05420948 · RECRUITING

Trial details

NCT number: NCT05420948
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Neoplasms Head Cancer Throat Carcinoma

Start date: 2022-10-17
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.